EB
ALXN

Eastern Bank’s Alexion Pharmaceuticals ALXN Stock Holding History

Eastern Bank’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,000
Closed -$245K – 217
2016
Q4 		$245K Hold
2,000
– – 0.02% 180
2016
Q3 		$245K Hold
2,000
– – 0.02% 179
2016
Q2 		$234K Hold
2,000
– – 0.02% 191
2016
Q1 		$278K Hold
2,000
– – 0.02% 172
2015
Q4 		$382K Hold
2,000
– – 0.03% 155
2015
Q3 		$313K Hold
2,000
– – 0.03% 166
2015
Q2 		$362K Hold
2,000
– – 0.03% 155
2015
Q1 		$347K Hold
2,000
– – 0.03% 159
2014
Q4 		$370K Hold
2,000
– – 0.03% 164
2014
Q3 		$332K Hold
2,000
– – 0.03% 166
2014
Q2 		$313K Hold
2,000
– – 0.03% 175
2014
Q1 		$304K Buy
+2,000
New +$318K 0.03% 178

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return